BR9804505A - Produção de um metabólito de licopeno - Google Patents
Produção de um metabólito de licopenoInfo
- Publication number
- BR9804505A BR9804505A BR9804505-9A BR9804505A BR9804505A BR 9804505 A BR9804505 A BR 9804505A BR 9804505 A BR9804505 A BR 9804505A BR 9804505 A BR9804505 A BR 9804505A
- Authority
- BR
- Brazil
- Prior art keywords
- pentadienol
- vii
- subjected
- metabolite
- cyclopentylbutenone
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 150000000648 7,7',9,9'-tetra-cis-lycopenes Chemical class 0.000 title 1
- ZJEQWUJYBZCXFH-MQQKCMAXSA-N (1e,3e)-penta-1,3-dien-1-ol Chemical compound C\C=C\C=C\O ZJEQWUJYBZCXFH-MQQKCMAXSA-N 0.000 abstract 5
- XEXZRDCAENYHAV-UHFFFAOYSA-N 1-cyclopentylbut-3-en-2-one Chemical compound C=CC(=O)CC1CCCC1 XEXZRDCAENYHAV-UHFFFAOYSA-N 0.000 abstract 5
- VELDYOPRLMJFIK-UHFFFAOYSA-N cyclopentanecarbaldehyde Chemical compound O=CC1CCCC1 VELDYOPRLMJFIK-UHFFFAOYSA-N 0.000 abstract 3
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 abstract 3
- 239000002207 metabolite Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- SDVVLIIVFBKBMG-UHFFFAOYSA-N penta-2,4-dienoic acid Chemical compound OC(=O)C=CC=C SDVVLIIVFBKBMG-UHFFFAOYSA-N 0.000 abstract 3
- 150000004714 phosphonium salts Chemical class 0.000 abstract 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract 2
- 238000007239 Wittig reaction Methods 0.000 abstract 2
- PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical compound OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical class CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract 2
- 229960004999 lycopene Drugs 0.000 abstract 2
- 235000012661 lycopene Nutrition 0.000 abstract 2
- 239000001751 lycopene Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract 2
- AYODHZHFDRRQEZ-UHFFFAOYSA-N 2,7-dimethylocta-2,4,6-trienedial Chemical compound O=CC(C)=CC=CC=C(C)C=O AYODHZHFDRRQEZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 230000005907 cancer growth Effects 0.000 abstract 1
- 235000021466 carotenoid Nutrition 0.000 abstract 1
- 150000001747 carotenoids Chemical class 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- RMGJCSHZTFKPNO-UHFFFAOYSA-M magnesium;ethene;bromide Chemical compound [Mg+2].[Br-].[CH-]=C RMGJCSHZTFKPNO-UHFFFAOYSA-M 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- OWUJMRYOLTVQND-UHFFFAOYSA-N triphenyl(3,7,11-trimethyldodeca-2,4,6,10-tetraenyl)phosphanium Chemical compound C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CC=C(C)C=CC=C(C)CCC=C(C)C)C1=CC=CC=C1 OWUJMRYOLTVQND-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/06—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
- C07C47/26—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups
- C07C47/267—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5435—Cycloaliphatic phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Patente de Invenção: <B>"PRODUçãO DE UM METABóLITO DE LICOPENO"<D>. A invenção refere-se a um processo de estágios múltiplos para a fabricação de um metabólito oxidativo do carotenóide licopeno 2,6-ciclolicopeno--1,5-diol da fórmula Começando do acetato de <244>-terpinila, esse é diidroxilado oxidativamente para um cicloexanodiol (IV), o cicloexanodiol (IV) é clivado oxidativamente para um cetoaldeído (V), o cetoaldeído (V) é submetido a uma condensação aldólica intramolecular para fornecer um ciclopentanol (VI), o ciclopentanol (VI) é sililado para a obtenção do seu derivado sililado [formilciclopentano (VII)], o formilciclopentano (VII) é submetido a um prolongamento de cadeia C~ 3~ com acetona e simultaneamente a uma saponificação para a clivagem do grupo acetil para fornecer uma ciclopentilbutenona (VII), a ciclopentilbutenona (VIII) é reagida com brometo de vinilmagnésio para fornecer um pentadienol (IX), o pentadienol (IX) é convertido com desproteção do grupo hidróxi sililado em um sal de fosfónio (X), esse sal é submetido a uma reação de Wittig com o 2,7-dimetil-2,4,6-octatrieno-1,8-dial para fornecer um tridecaexaenal (XII) e o tridecaexaenal (XII) é submetido a uma reação de Wittig com um sal de (3,7,11-trimetil-dodeca-2,4,6,10-tetraenil)trifenilfosfónio para fornecer o 2,6-ciclolicopeno-1,5-diol (II) desejado. Uma variação desse processo, que está igualmente de acordo com a invenção, compreende converter a ciclopentilbutenona (VIII) no sal de fosfónio (X) não através do pentadienol (IX), mas através de dois intermediários alternativos; a saber um éster do ácido pentadienóico (XIV) e um pentadienol (XV) diferente, no mesmo sal de fosfónio (X). Além disso, a invenção refere-se aos intermediários novos (V), (VI), (VII), (VIII), (IX), (X), (XII), (XIV) bem como ao (XV) e às etapas individuais do processo que levam a esses intermediários novos. O metabólito 2,6-ciclolicopeno-1,5-diol então obtido exibe atividade na prevenção do crescimento do câncer em células humanas e pode ser usado correspondentemente.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97118144 | 1997-10-20 | ||
EP98115249 | 1998-08-13 | ||
US09/168,143 US6008417A (en) | 1997-10-20 | 1998-10-07 | Process for making metabolites of lycopene |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9804505A true BR9804505A (pt) | 2001-05-02 |
Family
ID=27238303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9804505-9A BR9804505A (pt) | 1997-10-20 | 1998-10-19 | Produção de um metabólito de licopeno |
Country Status (9)
Country | Link |
---|---|
US (4) | US6008417A (pt) |
EP (1) | EP0911311B1 (pt) |
JP (1) | JPH11189560A (pt) |
CN (1) | CN1098243C (pt) |
BR (1) | BR9804505A (pt) |
CA (1) | CA2250627A1 (pt) |
DE (1) | DE59808241D1 (pt) |
DK (1) | DK0911311T3 (pt) |
ES (1) | ES2197408T3 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4513299A (en) * | 1998-06-15 | 2000-01-05 | Lonza A.G. | Procedure for producing formyl imidazoles |
US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
EP1532108B1 (en) | 2002-07-29 | 2016-06-29 | Cardax Pharma, Inc. | Astaxanthin esters for the inhibition and amelioration of disease |
US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US7375133B2 (en) | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
US20050009788A1 (en) * | 2002-07-29 | 2005-01-13 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling connexin 43 expression |
US20050026874A1 (en) * | 2002-07-29 | 2005-02-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease |
US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US7401104B2 (en) * | 2003-08-21 | 2008-07-15 | Microsoft Corporation | Systems and methods for synchronizing computer systems through an intermediary file system share or device |
ATE526332T1 (de) | 2004-04-30 | 2011-10-15 | Daiichi Seiyaku Co | Verfahren zur herstellung von pentacyclischem taxan |
US20090099061A1 (en) * | 2006-01-27 | 2009-04-16 | Foss Bente J | Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
US8063101B2 (en) * | 2007-03-23 | 2011-11-22 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs and derivatives for the prevention of platelet aggregation |
CN104592076A (zh) * | 2013-10-30 | 2015-05-06 | 浙江医药股份有限公司新昌制药厂 | α-胡萝卜素的制备方法 |
US10590152B2 (en) | 2017-12-14 | 2020-03-17 | International Business Machines Corporation | Pinene-based flame retardant compounds |
EP3712209A1 (en) | 2019-03-21 | 2020-09-23 | SABIC Global Technologies B.V. | High stiff thermoplastic compositions for thin-wall structures |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3781314A (en) * | 1971-07-14 | 1973-12-25 | Hoffmann La Roche | Polyene compounds |
DE2554924C3 (de) * | 1975-12-06 | 1979-07-12 | Dr. Friedrich-Karl Marcus Chemische Fabrik Kg, 2054 Geesthacht | Verfahren zur Herstellung von Lycopin |
US5166445A (en) * | 1989-02-10 | 1992-11-24 | Hoffman-La Roche Inc. | Method for the manufacture of carotinoids and the novel intermediates |
-
1998
- 1998-10-07 US US09/168,143 patent/US6008417A/en not_active Expired - Fee Related
- 1998-10-15 DE DE59808241T patent/DE59808241D1/de not_active Expired - Fee Related
- 1998-10-15 ES ES98119473T patent/ES2197408T3/es not_active Expired - Lifetime
- 1998-10-15 DK DK98119473T patent/DK0911311T3/da active
- 1998-10-15 EP EP98119473A patent/EP0911311B1/de not_active Expired - Lifetime
- 1998-10-16 CA CA002250627A patent/CA2250627A1/en not_active Abandoned
- 1998-10-19 BR BR9804505-9A patent/BR9804505A/pt not_active Application Discontinuation
- 1998-10-19 JP JP10295964A patent/JPH11189560A/ja not_active Withdrawn
- 1998-10-20 CN CN98121387A patent/CN1098243C/zh not_active Expired - Fee Related
-
1999
- 1999-05-12 US US09/310,280 patent/US6040475A/en not_active Expired - Fee Related
- 1999-10-12 US US09/416,453 patent/US6204414B1/en not_active Expired - Fee Related
-
2000
- 2000-09-13 US US09/660,981 patent/US6271408B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0911311T3 (da) | 2003-08-25 |
DE59808241D1 (de) | 2003-06-12 |
CA2250627A1 (en) | 1999-04-20 |
JPH11189560A (ja) | 1999-07-13 |
CN1218026A (zh) | 1999-06-02 |
US6040475A (en) | 2000-03-21 |
EP0911311B1 (de) | 2003-05-07 |
US6204414B1 (en) | 2001-03-20 |
CN1098243C (zh) | 2003-01-08 |
US6271408B1 (en) | 2001-08-07 |
EP0911311A1 (de) | 1999-04-28 |
US6008417A (en) | 1999-12-28 |
ES2197408T3 (es) | 2004-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9804505A (pt) | Produção de um metabólito de licopeno | |
CA1058625A (en) | Manufacture of symmetrical carotenoids | |
Van Woerden | Organic Sulfites. | |
Ballou et al. | The synthesis of dihydroxyacetone phosphate | |
Walling et al. | The reaction of thiyl radicals with trialkyl phosphites1 | |
WO2006039685A2 (en) | Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives | |
AR015932A1 (es) | Procedimiento para la preparacion de glufosinatos a traves de aminonitrilos que contienen fosforo y compuestos intermediarios seleccionados de acetales o semiacetales que contienen fosforo o 1,2-oxifosfolenos | |
Nelson et al. | 13-Desmethyl rhodopsin and 13-desmethyl isorhodopsin: visual pigment analogues | |
US2963505A (en) | Sulphoxides-containing esters of the phosphoric and thiophosphoric acids | |
Greenhalgh et al. | Ultraviolet irradiation of fenitrothion and the synthesis of the photolytic oxidation products | |
Tamaru et al. | Palladium-catalyzed thiono-thiolo allylic rearrangement of O-allyl phosphoro-and phosphonothionates | |
ES2148852T3 (es) | Procedimiento para la fabricacion continua de carbonatos de arilo. | |
EP0895997B1 (de) | Verfahren zur Herstellung von Phosphoniumsalzen | |
Oswald et al. | Organic Sulfur Compounds. IX. 1 Addition of Diethyldithiophosphoric Acid to Dienes | |
Shiraishi et al. | Quinones. Part 3. Synthesis of quinone derivatives having ethylenic and acetylenic bonds: specific inhibitors of the formation of leukotrienes and 5-hydroxyicosa-6, 8, 11, 14-tetraenoic acid (5-HETE) | |
Miyamoto et al. | Reaction of phosphinyl and phosphinothioyl disulfides with diazomethane | |
Michalski et al. | 335. Organophosphorus compounds of sulphur and selenium. Part XV. Reactions of organic thiosulphonates with trialkyl phosphites and dialkyl phosphites | |
Rosenberger | Retinoic acid metabolites. 1. Total synthesis of 4-hydroxy-and 4-oxoretinoic acid | |
Barton et al. | 369. Photochemical transformations. Part XIII. A new method for the production of acyl radicals | |
Sribney et al. | The Enzymatic Synthesis of SPHINGOMYELIN1 | |
Fiksdahl et al. | Diacetylenic carotenoids from Euglena viridis | |
Eskandari et al. | Synthesis of α, β-unsaturated epoxy ketones utilizing a bifunctional sulfonium/phosphonium ylide | |
GB1508195A (en) | Process for the manufacture of optically active cyclohexane derivatives | |
SUEMUNE et al. | Synthetic studies on platelet-activating factor (PAF) | |
CA1108176A (en) | Arylalkyl and aryloxyalkyl phosphonates and preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Free format text: DSM IP ASSETS B.V. (NL) |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |